-
2023-507419-37-00
5
2020-06-25
Plasma cell myeloma
-
2023-503591-25-00
5
2020-06-09
Non-small cell lung cancer
-
2022-501531-16-00
5
2020-01-24
esophageal carcinoma
-
2023-506112-40-00
5
2018-09-26
R/R Multiple Myeloma
-
2023-503469-49-00
5
2018-04-19
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
-
2022-502653-34-01
11
2024-05-30
Atopic dermatitis and moderate-to severe atopic hand eczema
-
2023-505499-32-00
5
2024-03-08
Uncontrolled hypertension (uTHN) defined as blood pressure that remain
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2022-502778-18-00
5
2023-11-17
ulcerative colitis
-
2022-502370-17-00
4
2023-11-14
Hidradenitis suppurativa
-
2022-502540-12-00
5
2023-11-09
Refractory Status Epilepticus (RSE)
-
2022-500777-14-00
4
2023-11-06
Atopic Dermatitis
-
2022-501883-17-00
5
2023-10-16
Contrast enhancement in magnetic resonance imaging in children
-
2022-502057-33-00
7
2023-10-02
Relapsed/refractory multiple myeloma
-
2022-501884-41-00
5
2023-09-29
Contrast enhancement in magnetic resonance imaging for assessment of c
-
2022-501885-24-00
5
2023-09-20
Contrast enhancement in magnetic resonance imaging for assessment of n
-
2022-502393-16-00
5
2023-09-06
Moderately to Severely Active Ulcerative Colitis
-
2022-502196-31-00
10
2023-08-21
Advanced or Recurrent Endometrial Cancer
-
2022-500536-11-01
5
2023-06-08
Moderately to severely active ulcerative colitis
-
2023-503793-20-00
5
2023-01-18
Prevention of ischemic stroke in patients post acute non-cardioembolic
-
2023-503797-21-00
5
2022-08-10
Metastatic Colorectal Cancer
-
2024-511560-93-00
5
2022-03-29
Schizophrenia
-
2023-507688-20-00
5
2021-12-03
Participants with completely resected Stage III or Stage IV melanoma
-
2022-500752-39-00
5
2021-11-25
Prevention of Respiratory syncytial virus (RSV) infection in infants a